Study finds diagnosis mistakes lead lawsuits against ER doctors
Emergency room doctors in New York and across the country face a number of challenges, including lack of staff, insufficient medical records and language barriers. A new study from The […]
Software may help surgeons with spine operations
New York patients may be interested to learn that researchers at Johns Hopkins reportedly developed a software program that helps surgeons identify the different vertebrae. This program, which labels the […]
Xarelto Lawsuits Filed
A press release yesterday announced New York City law firm of Rheingold Giuffra Ruffo Plotkin & Hellman LLP (Rheingold Giuffra Ruffo Plotkin & Hellman LLP) commenced two wrongful death lawsuits […]
Complications associated with laser surgery
As many New York residents know, laser surgery is used extensively in a variety of areas. Both physicians and non-physicians perform laser procedures, and uniform training requirements are lacking on […]
Committee Votes to Change Labels for Onglyza and Nesina
A Food and Drug Administration advisory committee met Tuesday to discuss diabetes drugs made by AstraZeneca and Takeda Pharmaceutical. Although the Endocrinologic and Metabolic Drugs Advisory Committee found the drugs’ […]
Onglyza May Increase Death Rate According to FDA
According to a preliminary report by the Food and Drug Administration (FDA), Onglyza, AstraZeneca’s diabetes drug, could possibly be associated with an increased rate of death. The report, which was […]
Zofran and Hypospadias: Possible Link Indicated in 2004 Medical Journal
As we have written about previously, the Zofran litigation against GlaxoSmithKline is rapidly developing. The drug maker marketed Zofran, an anti-nausea medication, for use during pregnancy without having tested its […]
Despite Record Settlement GlaxoSmithKline Continues to Deny Zofran May Cause Birth Defects
A record setting settlement of $3 billion was signed between the Department of Justice and GlaxoSmithKline (GSK) in 2012. Among the accusations of the lawsuit, the Department of Justice alleged […]
Unnecessary medical tests have potential to harm patients
Although doctors order extra tests in an effort to avoid missing a diagnosis, unnecessary medical tests could impose risks as well as higher costs on New York patients. Unnecessary testing […]
New Lawsuits Against GSK For Zofran
New information has been released regarding GlaxoSmithKline’s anti-nausea drug Zofran. According to the report, by a combination of Plaintiff’s attorneys, recent studies have begunto establish a connection between Ondansetron, Zofran’s […]